I am with you horsemin. I think people waiting for these results and FDA feedback to consolidate holdings. IMO this will then push the emphasis to a licencing agreement which should occur soon after. Worthind has shown that the market for this drug is definitely there and it is going to make AVX very good money even on a 20% agreement. I am still looking for the exit door, but if all comes to plan this BIO could fly and offer us returns like ADO holders were enjoying for a couple of days. That would make the exit door a nice gold one indeed. At least this is what I am hoping, but I feel it may still only make me my money back! All my opinions only so DYOR.
Watching, waiting, hoping, holding. GLTA.
sads.
AVX Price at posting:
15.5¢ Sentiment: Hold Disclosure: Held
